Press Releases

Proscia And Smart Reporting Partner To Help Pathologists Guide Clinical Care Teams

Proscia and Smart Reporting have partnered to help pathologists inform treatment decisions.

Medical University of Graz Selects the HALO AP® Digital Pathology Platform to Deliver Comprehensive Diagnostics

Indica Labs has announced the Diagnostics & Research Institute for Pathology at the Medical University of Graz has selected the HALO AP® digital pathology platform from Indica Labs to deliver primary diagnostics, alongside Aperio GT 450 scanners from Leica Biosystems.

Indica Labs and Paige Forge Strategic Partnership to Expand Integrated AI for Anatomic Pathology Labs

Indica Labs and Paige have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP®.

Baylor Genetics to Offer Webinar, “RNAseq: Enhancing Rare Disease Insights from WES & WGS”

Baylor Genetics, a joint venture clinical diagnostic laboratory at the forefront of genetic testing, will host a webinar, “RNAseq: Enhancing Rare Disease Insights from WES & WGS,” that will explore the company’s new RNAseq offering and its impact on advancing rare disease insights from Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS).

PathAI's AISightⓇ Dx Image Management System is CE Marked for Primary Diagnosis

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that its AISightⓇ Dx Image Management System (IMS) is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis. The CE mark paves the way for the company's expansion in the European diagnostic pathology market, enhancing pathologists' interpretations and driving efficiencies and quality improvements within anatomic pathology laboratories.

Gene by Gene Expands NGS Capabilities with New Tech Investment

Association for Molecular Pathology Files Lawsuit Against FDA to Challenge Final Rule on Regulation for Laboratory Developed Testing Procedures

The Association for Molecular Pathology and world-renowned pathologist Michael Laposata, MD, PhD, today announced the filing of a lawsuit challenging the recent U.S. Food and Drug Administration (FDA) Rule that regulates laboratory developed test (LDT) procedures.

International Consortium to Revolutionize Viral Vector Manufacturing

Abselion has announced the collaboration of leading biotechnology companies and research organizations in UK and Canada to develop next-generation cell platform for viral vector production.

Biopharma PEG Expands Multi-Arm PEG Product Line for Medical and Biopharma Applications

Phastar named in 2024 Environment 100 List

Phastar named in 2024 Environment 100 List Phastar continues to lead the CRO industry in corporate responsibility as CEO Graham Clark is named in list of trailblazers, innovators and visionaries.

eClinical Solutions Introduces Protocol Deviations Among New Product Innovations Boosting Operational Success for Clinical Trials

eClinical Solutions announced newly released product enhancements and AI-enabled functionality within the elluminate Clinical Data Cloud ®. Recent platform updates offer clinical teams increased oversight and efficiency amid trial complexity and advance the AI technology footprint of life sciences organizations.

PathAI Announces Launch of AI-based Measurement of Metabolic Dysfunction-Associated Steatohepatitis ("AIM-MASH") on the AISight Image Management System

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, is proud to announce the launch of its AIM-MASH product on the AISightⓇ Image Management System (IMS). This product provides advanced AI-based measurement (AIM) to support the analysis of MASH Clinical Research Network (CRN) Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Activity Score (MAS) component grades and fibrosis staging. The launch of AIM-MASH on AISight aims to increase the reproducibility and scalability of pathologists' assessments and management of MASH cases, which are projected to reach 27 million in the US alone by 2030.

Healthcasts Updates Provider Consult and Research Tool

Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to Patients

Baylor Genetics, a joint venture clinical diagnostic laboratory at the forefront of genetic testing, and the Department of Molecular and Human Genetics at Baylor College of Medicine have entered a lab agreement focusing on innovation and high-risk projects that have potentially great clinical impact. This latest collaboration allows for the translation of cutting-edge research into clinical diagnostics, benefiting from BCM’s academic and medical expertise and the clinical diagnostic expertise of Baylor Genetics, in anticipation of larger scale launch when commercially feasible

Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows

Indica Labs has announced the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.

Longhorn Vaccines and Diagnostics Provides Mid-Year Progress on Vaccine and Diagnostic Divisions

AVIA’s Generative AI Strategic Collaborative Enters Phase 2, Accelerating Healthcare AI Adoption and Real-World Applications

Clearwater Managed Cloud Services Help Healthcare Organizations Leverage the Power of Microsoft Azure with Reduced Risk

Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation

Clinion, a Lifescience technology company based out of the US, UK and India, has won a category award in the 2024 Clinical Trials Arena Excellence Awards

Creative BioMart Expands Native Proteins Offering to Advance Scientific Research and Discovery